XRAY vs. OWL
XRAY (DENTSPLY SIRONA Inc.) and OWL (Blue Owl Capital Inc.) are both stocks. XRAY operates in Medical Instruments & Supplies (Healthcare), while OWL operates in Asset Management (Financial Services). Over the past 5 years, XRAY returned -29.30%/yr vs -1.67%/yr for OWL. At a 0.34 correlation, their price movements are largely independent.
Performance
XRAY vs. OWL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XRAY achieves a -11.20% return, which is significantly higher than OWL's -35.51% return.
XRAY
- 1D
- -1.74%
- 1M
- -0.59%
- YTD
- -11.20%
- 6M
- -8.55%
- 1Y
- -31.40%
- 3Y*
- -34.00%
- 5Y*
- -29.30%
- 10Y*
- -15.25%
OWL
- 1D
- -3.15%
- 1M
- -8.25%
- YTD
- -35.51%
- 6M
- -39.33%
- 1Y
- -47.15%
- 3Y*
- -1.02%
- 5Y*
- -1.67%
- 10Y*
- —
XRAY vs. OWL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
XRAY DENTSPLY SIRONA Inc. | -11.20% | -36.84% | -45.28% | 13.50% | -42.11% | 7.32% | -0.94% |
OWL Blue Owl Capital Inc. | -35.51% | -32.83% | 61.76% | 47.40% | -26.29% | 32.18% | 5.86% |
Correlation
The correlation between XRAY and OWL is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.37 |
Correlation (All Time) Calculated using the full available price history since Dec 14, 2020 | 0.34 |
Fundamentals
XRAY:
$2.03B
OWL:
$6.29B
XRAY:
-$3.15
OWL:
$0.13
XRAY:
0.55
OWL:
2.10
XRAY:
1.54
OWL:
2.99
XRAY:
$3.68B
OWL:
$2.94B
XRAY:
$1.80B
OWL:
$1.99B
XRAY:
-$222.00M
OWL:
$876.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XRAY vs. OWL — Risk / Return Rank
XRAY
OWL
XRAY vs. OWL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DENTSPLY SIRONA Inc. (XRAY) and Blue Owl Capital Inc. (OWL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XRAY | OWL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.36 | ||
| Sortino ratioReturn per unit of downside risk | +0.77 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 0.81 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.76 | -0.81 | +0.04 |
| Martin ratioReturn relative to average drawdown | -1.20 | -1.38 | +0.18 |
Loading charts...
Drawdowns
XRAY vs. OWL - Drawdown Comparison
The maximum XRAY drawdown since its inception was -84.45%, which is greater than OWL's maximum drawdown of -67.10%. Use the drawdown chart below to compare losses from any high point for XRAY and OWL.
Loading charts...
Drawdown Indicators
| XRAY | OWL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.45% | -67.10% | -17.35% |
Max Drawdown (1Y)Largest decline over 1 year | -41.20% | -58.59% | +17.39% |
Max Drawdown (3Y)Largest decline over 3 years | -74.81% | -67.10% | -7.71% |
Max Drawdown (5Y)Largest decline over 5 years | -83.92% | -67.10% | -16.82% |
Max Drawdown (10Y)Largest decline over 10 years | -84.45% | — | — |
Current DrawdownCurrent decline from peak | -83.63% | -62.23% | -21.40% |
Average DrawdownAverage peak-to-trough decline | -20.53% | -24.27% | +3.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.17% | 34.15% | -7.98% |
Volatility
XRAY vs. OWL - Volatility Comparison
The current volatility for DENTSPLY SIRONA Inc. (XRAY) is 11.49%, while Blue Owl Capital Inc. (OWL) has a volatility of 13.36%. This indicates that XRAY experiences smaller price fluctuations and is considered to be less risky than OWL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XRAY | OWL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.49% | 13.36% | -1.87% |
Volatility (6M)Calculated over the trailing 6-month period | 34.07% | 34.70% | -0.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.58% | 44.23% | +0.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.55% | 42.08% | -4.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.77% | 42.76% | -7.99% |
Dividends
XRAY vs. OWL - Dividend Comparison
XRAY's dividend yield for the trailing twelve months is around 4.73%, less than OWL's 9.80% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OWL Blue Owl Capital Inc. | 9.80% | 5.72% | 2.92% | 3.69% | 4.06% | 0.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XRAY DENTSPLY SIRONA Inc. | 4.73% | 5.60% | 3.37% | 1.57% | 1.57% | 0.77% | 0.76% | 0.66% | 0.94% | 0.53% | 0.54% | 0.48% |
Financials
XRAY vs. OWL - Financials Comparison
This section allows you to compare key financial metrics between DENTSPLY SIRONA Inc. and Blue Owl Capital Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XRAY vs. OWL - Profitability Comparison
XRAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DENTSPLY SIRONA Inc. reported a gross profit of 427.00M and revenue of 880.00M. Therefore, the gross margin over that period was 48.5%.
OWL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Blue Owl Capital Inc. reported a gross profit of 753.81M and revenue of 753.81M. Therefore, the gross margin over that period was 100.0%.
XRAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DENTSPLY SIRONA Inc. reported an operating income of -35.00M and revenue of 880.00M, resulting in an operating margin of -4.0%.
OWL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Blue Owl Capital Inc. reported an operating income of 109.49M and revenue of 753.81M, resulting in an operating margin of 14.5%.
XRAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DENTSPLY SIRONA Inc. reported a net income of -10.00M and revenue of 880.00M, resulting in a net margin of -1.1%.
OWL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Blue Owl Capital Inc. reported a net income of 15.54M and revenue of 753.81M, resulting in a net margin of 2.1%.
Frequently Asked Questions
XRAY and OWL have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OWL has higher volatility (13.36%) compared to XRAY (11.49%). In terms of maximum drawdown, XRAY dropped -84.45% vs OWL's -67.10%.
XRAY currently has the higher Sharpe Ratio (-0.71 vs -1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XRAY and OWL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer